Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7155)
All Articles published online
|
Publishing Process of This Article
|
Aug 26, 2016 (publication date) through Apr 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Stem Cells
ISSN
1948-0210
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Garg M. Epithelial plasticity in urothelial carcinoma: Current advancements and future challenges. World J Stem Cells 2016; 8(8): 260-267 [PMID: 27621760 DOI: 10.4252/wjsc.v8.i8.260] |
|---|---|
| URL: | https://www.wjgnet.com/1948-0210/full/v8/i8/260.htm |
| Number | Citing Articles |
| 1 |
Xiaopeng Mao, Baimou Li, Ying Liang, Shuhua Li, Jianwen Zhou, Qiong He, Neng Jiang, Yangshan Chen, Yu Sun, Yongmei Cui, Wenting Jiang, Han Wang, Liantang Wang, Zunfu Ke. Auxiliary diagnostic value of p16 amplification combined with the detection of heterozygous and homozygous loss for urothelial carcinoma. Oncology Letters 2018; doi: 10.3892/ol.2018.8137
|
| 2 |
Huanjun Wang, Yan Mei, Cheng Luo, Qun Huang, Zifeng Wang, Guan-Ming Lu, Lili Qin, Zhun Sun, Chao-Wen Huang, Zhi-Wen Yang, Junxing Chen, Weiguo Yin, Chao-Nan Qian, Jianming Zeng, Lingwu Chen, Qibin Leng, Yan Guo, Guangshuai Jia. Single-Cell Analyses Reveal Mechanisms of Cancer Stem Cell Maintenance and Epithelial–Mesenchymal Transition in Recurrent Bladder Cancer. Clinical Cancer Research 2022; 27(22): 6265 doi: 10.1158/1078-0432.CCR-20-4796
|
| 3 |
Zhao Zhang, Yongbo Yu, Peng Li, Meilan Wang, Wei Jiao, Ye Liang, Haitao Niu. Identification and validation of an immune signature associated with EMT and metabolic reprogramming for predicting prognosis and drug response in bladder cancer. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.954616
|
| 4 |
Burak Ucpinar, Jordan Miller Rich, Kennedy E. Okhawere, Shirin Razdan, Osama Zaytoun, Laura Zuluaga, Indu Saini, Michael D. Stifelman, Ronney Abaza, Daniel D. Eun, Akshay Bhandari, Ashok K. Hemal, James Porter, Simone Crivellero, Ahmed Mansour, Phillip M. Pierorazio, Ketan K. Badani. Robot-assisted partial nephrectomy for complex renal tumors: Analysis of a large multi-institutional database. Urologic Oncology: Seminars and Original Investigations 2023; 41(8): 358.e9 doi: 10.1016/j.urolonc.2023.05.016
|
| 5 |
O. N. Sulayeva, A. A. Seleznev, R. N. Ponomarchuk, A. E. Stakhovskyi, D. A. Shapochka. The bladder cancer: the risk factors and prognostic markers. Klinicheskaia khirurgiia 2019; 86(11-12): 78 doi: 10.26779/2522-1396.2019.11-12.78
|
| 6 |
Dong Fang, Hiroshi Kitamura. Cancer stem cells and epithelial–mesenchymal transition in urothelial carcinoma: Possible pathways and potential therapeutic approaches. International Journal of Urology 2018; 25(1): 7 doi: 10.1111/iju.13404
|
| 7 |
Minal Garg, Niharika Maurya. WNT/β-catenin signaling in urothelial carcinoma of bladder. World Journal of Nephrology 2019; 8(5): 83-94 doi: 10.5527/wjn.v8.i5.83
|
| 8 |
Zainab Siddiqui, Anand N. Srivastava, Satya N. Sankhwar, Noorin Zaidi, Naseem Fatima, Shivangi Singh, Mohd. Yusuf. Oct-4: a prognostic biomarker of urinary bladder cancer in North India. Therapeutic Advances in Urology 2019; 11: 175628721987557 doi: 10.1177/1756287219875576
|
| 9 |
Umar Ahmad, Buhari Ibrahim, Mustapha Mohammed, Ahmed Faris Aldoghachi, Mahmood Usman, Abdulbasit Haliru Yakubu, Abubakar Sadiq Tanko, Khadijat Abubakar Bobbo, Usman Adamu Garkuwa, Abdullahi Adamu Faggo, Sagir Mustapha, Mahmoud Al‐Masaeed, Syahril Abdullah, Yong Yoke Keong, Abhi Veerakumarasivam. Transcriptome profiling research in urothelial cell carcinoma. Applied Research 2023; doi: 10.1002/appl.202300002
|
| 10 |
Feng-Che Kuan, Jhy-Ming Li, Yun-Ching Huang, Shun-Fu Chang, Chung-Sheng Shi. Therapeutic Potential of Regorafenib in Cisplatin-Resistant Bladder Cancer with High Epithelial–Mesenchymal Transition and Stemness Properties. International Journal of Molecular Sciences 2023; 24(24): 17610 doi: 10.3390/ijms242417610
|